T.CelestinoI.CoppoL.HolmgrenA.et al (2017)
Semaglutide does not directly affect potassium, but the gastrointestinal side effects sometimes associated with GLP-1 medicationssuch as vomiting or diarrheacan disrupt your overall electrolyte balance
Its available on prescription through the NHS and, like tirzepatide , should only be taken under medical supervision if you meet the eligibility criteria
No known pharmacologic agent is effective
Introduction Strategies to prevent or ameliorate heart failure (HF) remain urgently needed ( Within the past 2 decades, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as effective agents to improve glycaemic control in type 2 diabetes and to reduce body weight in people with overweight or obesity ( In this article, we review current evidence suggesting a potential benefit of GLP-1 RAs in HF as well as the current understanding of the putative mechanistic underpinnings
In our model, cells primed with Exendin-4 presented higher glycolytic rates when returned to culture media in the absence of GLP-1R stimulation